Zohar 2009.
Trial name or title | PTSD prevention using escitalopram |
Methods | Allocation: randomised Intervention model: parallel assignment Masking: double‐blind (subject, investigator) Primary purpose: prevention |
Participants | Ages eligible for study:18 years to 65 years Genders eligible for study: both Accepts healthy volunteers: no |
Interventions | Pharmacological intervention: 10 to 20 mg/day of escitalopram versus 1/2 capsules of placebo |
Outcomes | Primary outcome: CAPS Secondary outcomes: no information provided |
Starting date | June 2005 |
Contact information | Contact: Joseph Zohar, MD: jzohar@post.tau.ac.il |
Notes | Assessment of primary outcome at 1‐year follow‐up |